CDMO News
Minafin’s Health Chemistry Division Welcomes New CEO, Olivier Ubrich
The Minafin Group has appointed Olivier Ubrich as CEO of its Health Chemistry division, which encompasses Minakem CDMO and Minakem Generics & New Therapies. Ubrich, who joins the Minafin Executive Committee, brings extensive international experience. He previously held leadership roles
5 September 2024